Effects of Lactiplantibacillus plantarum VB165 on gut microbiota of Insulin-Resistant Mice
This study investigated the effects of Lactiplantibacillus plantarum VB165, a probiotic strain with intrinsic Alpha glucosidase inhibitor (AGI) activity, on metabolic disorders in high-fat diet (HFD)-induced insulin-resistant (IR) mice. L. plantarum VB165 improves HFD-induced metabolic disorders via multi-target mechanisms, modulated gut microbiota community composition, suppressing HFD-enriched genera and promoting beneficial taxa.